NEW DELHI/MUMBAI, Jan 18 (Reuters) - India's largest drugmaker, Ranbaxy Laboratories Ltd. (RANB.BO: Quote, Profile, Research) , reported a 56 percent drop in quarterly profit on Wednesday due to price pressures in the U.S. market and said it had a new chief executive.
